METHOD OF TREATMENT OF ATOPIC DERMATITIS Russian patent published in 2008 - IPC A61K35/14 A61K31/4402 A61K31/56 A61P37/02 

FIELD: medicine.

SUBSTANCE: for treatment of atopic dermatitis, use the autologous T-lymphocytes, activated with the help of anti CD3 antibodies and interleukin-2. The activated T-lymphocytes are administered subcutaneously once a week within 4 weeks and further once a month within one year. Simultaneously perform basic therapy by antihistamine preparations and topical glucocorticosteroids.

EFFECT: depression of clinical implications of disease at the expense of influence on the changed immune response through an induction of the antiergotypical response.

2 ex